Biotechnology

SPRUCE BIOSCIENCES INC

SPRUCE BIOSCIENCES INC released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -3.4966 (forecast USD --)

SPRUCE BIOSCIENCES INC released FY2025 Semi-Annual earnings on August 14 (EST), with actual revenue of USD 0 and actual EPS of USD -27.3641

Spruce Biosciences Inc. released FY2024 Q1 earnings on May 6, 2025 (EST), actual revenue USD 2.002 M (forecast USD 1.158 M), actual EPS USD -21.2155

Spruce Biosciences Inc. released FY2025 Q1 earnings on May 6 (EST), actual revenue USD 0 (forecast USD 125K), actual EPS USD -23.9635

Spruce Biosciences Inc. released FY2023 Q4 earnings on April 15 (EST), actual revenue USD 2.887 M (forecast USD 1.329 M), actual EPS USD -18.2971

Spruce Biosciences Inc. released FY2024 earnings on April 15 (EST), actual revenue USD 4.911 M (forecast USD 5.093 M), actual EPS USD -96.3943

Spruce Biosciences Inc. released FY2024 Q4 earnings on April 15 (EST), actual revenue USD 697K (forecast USD 885K), actual EPS USD -42.5802

SPRUCE BIOSCIENCES INC released FY2023 earnings on April 15 (EST), actual revenue USD 10.09 M (forecast USD 8.529 M), actual EPS USD -93.3242

SPRUCE BIOSCIENCES INC released FY2023 Q3 earnings on November 12 (EST), actual revenue USD 3.073 M (forecast USD 1.5 M), actual EPS USD -22.7594

Spruce Biosciences Inc. released FY2024 Q3 earnings on November 12 (EST), actual revenue USD 602K (forecast USD 1.033M), actual EPS USD -15.7454

Spruce Biosciences Inc. released FY2024 9 Months Earnings on November 12 (EST), actual revenue USD 4.214 M, actual EPS USD -53.6889

Spruce Biosciences Inc. released FY2024 Semi-Annual Earnings on August 12 EST, with actual revenue of USD 3.612 M and EPS of USD -37.9398

Spruce Biosciences Inc. released FY2023 Q2 earnings on August 12 (EST), actual revenue USD 2.165 M (forecast USD 816.67 K), actual EPS USD -23.7201

Spruce Biosciences Inc. released FY2024 Q2 earnings on August 12 (EST), actual revenue USD 1.61 M (forecast USD 1.246 M), actual EPS USD -16.7295

Spruce Biosciences Inc. released FY2023 semi-annual earnings on August 12 (EST), actual revenue USD 4.129 M, actual EPS USD -52.9996

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

ADMA生物制药

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel制药

OpGen

福泰制药

再生元制药

Argenx

阿里拉姆制药

百济神州

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap